2017 Press Releases

2017 Press Releases

2017 | 2016 | 2015
  • Feb 27, 2017 

    Novavax Reports Fourth Quarter and Year-End 2016 Financial Results - 

    GAITHERSBURG, Md., Feb. 27, 2017 (GLOBE NEWSWIRE) -- Novavax, Inc., (Nasdaq:NVAX) today announced its financial results for the fourth quarter and twelve months ended December 31, 2016. Recent and Fourth Quarter Achievements: Continued execution of the global Phase 3 Prepare™ clinical trial to prevent RSV in infants via maternal immunization. Prepare is a randomized, observer-blinded, placebo-controlled trial, conducted at multiple international sites. The primary objective is to deter... More >>

  • Feb 20, 2017 

    Novavax to Host Conference Call to Discuss Fourth Quarter and Year-End 2016 Financial Results on February 27, 2017 - 

    GAITHERSBURG, Md., Feb. 20, 2017 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq:NVAX) today announced it will report its fourth quarter and full year 2016 financial and operating results following the close of U.S. financial markets on Monday, February 27, 2017. Conference call details are as follows: Date:   Monday, February 27, 2017 Time:   4:30 p.m. U.S. Eastern Time (ET) Dial-in number:   (877) 212-6076 (Domestic) or (707) 287-... More >>

  • Jan 19, 2017 

    Novavax Initiates Phase 2 Safety and Immunogenicity Trial of the RSV F Vaccine in Older Adults - 

    GAITHERSBURG, Md., Jan. 19, 2017 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq:NVAX) today announced the initiation of a Phase 2 clinical trial of its respiratory syncytial virus F-protein nanoparticle vaccine candidate (RSV F Vaccine) in older adults (60 years of age and older). The objective of the trial is to assess safety and immunogenicity to one and two dose regimens of the RSV F Vaccine, with and without aluminum phosphate or Novavax’ proprietary Matrix-M™ adjuvant, in older adults. The ... More >>

  • Jan 05, 2017 

    Novavax to Present at the 35th Annual J.P. Morgan Healthcare Conference - 

    GAITHERSBURG, Md., Jan. 05, 2017 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq:NVAX) today announced that management will present at the 35th Annual J.P. Morgan Healthcare Conference. Presentation details are as follows: Date: Thursday, January 12, 2017 Time: 9:30 am U.S. Pacific Time Location: California East room, Westin St. Francis Hotel, San Francisco Live webcast: novavax.com, “Investors”/ “Events” The webcast and replay of the presentation will also be accessible under the “Investors... More >>